- We will send in 10–14 business days.
/https://libri-media.knygos-static.lt/5ddc3ca3-9a4c-4715-a39c-218ce8984f6a/2)
- Author: Philip Anochie
- Publisher: LAP Lambert Academic Publishing
- Year: 2018
- Pages: 52
- ISBN-10: 3659694053
- ISBN-13: 9783659694059
- Format: 15 x 22 x 0.4 cm, minkšti viršeliai
- Language: English
- SAVE -10% with code: EXTRA
How To Control The Tuberculosis And HIV/AIDS Dual Epidemic (e-book) (used book) | bookbook.eu
Reviews
Description
TB patients can be offered an HIV test; indeed , research shows that TB patients are more likely to accept HIV testing than the general population. This means that TB programmes can make a major contribution to identifying eligible candidates for ARV treatment. Many people , including those living with HIV, do not know that TB is curable. This is a basic message and one thing that is failing to get through. We should know how to get the message to policy- makers and funders that more drugs are needed for both diseases. It is not ¿either/or¿, there is no point providing ARVs only for patients to die of TB for lack of TB resources. Similarly , TB efforts alone are insufficient. HIV/AIDS is dramatically fuelling the TB epidemic in sub-Saharan Africa, where up to 70% of TB patients are co-infected with HIV in some countries. For many years efforts to tackle TB and HIV have been largely separate, despite the overlapping epidemiology. Improved collaboration between TB and HIV/AIDS programmes will lead to more effective control of TB among HIV- infected people and to significant public health gains.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 23d.17:13:54
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Author: Philip Anochie
- Publisher: LAP Lambert Academic Publishing
- Year: 2018
- Pages: 52
- ISBN-10: 3659694053
- ISBN-13: 9783659694059
- Format: 15 x 22 x 0.4 cm, minkšti viršeliai
- Language: English English
TB patients can be offered an HIV test; indeed , research shows that TB patients are more likely to accept HIV testing than the general population. This means that TB programmes can make a major contribution to identifying eligible candidates for ARV treatment. Many people , including those living with HIV, do not know that TB is curable. This is a basic message and one thing that is failing to get through. We should know how to get the message to policy- makers and funders that more drugs are needed for both diseases. It is not ¿either/or¿, there is no point providing ARVs only for patients to die of TB for lack of TB resources. Similarly , TB efforts alone are insufficient. HIV/AIDS is dramatically fuelling the TB epidemic in sub-Saharan Africa, where up to 70% of TB patients are co-infected with HIV in some countries. For many years efforts to tackle TB and HIV have been largely separate, despite the overlapping epidemiology. Improved collaboration between TB and HIV/AIDS programmes will lead to more effective control of TB among HIV- infected people and to significant public health gains.
Reviews